Muhammad Shurafa
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 17
- Hemophilia Treatment and Research 6
- Acute Myeloid Leukemia Research 5
- Platelet Disorders and Treatments 4
- Blood Coagulation and Thrombosis Mechanisms 3
- Genetics 12
- Chronic Lymphocytic Leukemia Research 6
- Hemoglobinopathies and Related Disorders 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Kenneth J. Kopecky (3 shared papers)Frederick R. Appelbaum (3 shared papers)Cheryl L. Willman (2 shared papers)David R. Head (2 shared papers)James H. Doroshow (2 shared papers)Chatchada Karanes (2 shared papers)Diane L. Persons (1 shared paper)Harry E. Hynes (1 shared paper)
- Journals
- Blood (5 papers)American Journal of Hematology (3 papers)Genes Chromosomes and Cancer (2 papers)Archives of Pathology & Laboratory Medicine (2 papers)Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Muhammad Shurafa
28 papers receiving 893 citations
Peers
Comparison fields: 5 of 73
- Hematology 420
- Genetics 262
- Oncology 319
- Pathology and Forensic Medicine 142
- Gastroenterology 36
Countries citing papers authored by Muhammad Shurafa
This map shows the geographic impact of Muhammad Shurafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Shurafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Shurafa more than expected).
Fields of papers citing papers by Muhammad Shurafa
This network shows the impact of papers produced by Muhammad Shurafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Shurafa. The network helps show where Muhammad Shurafa may publish in the future.
Co-authors
The 25 scholars most cited alongside Muhammad Shurafa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 301 | |
| 2 | 2001 | 101 | |
| 3 | 2000 | 92 | |
| 4 | Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. | 2000 | 78 |
| 5 | 1987 | 42 | |
| 6 | 1998 | 41 | |
| 7 | 2000 | 39 | |
| 8 | 2007 | 34 | |
| 9 | 2004 | 31 | |
| 10 | 2000 | 31 | |
| 11 | 2001 | 16 | |
| 12 | Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial. | 1995 | 16 |
| 13 | 2000 | 10 | |
| 14 | 2003 | 9 | |
| 15 | 2004 | 9 | |
| 16 | 1987 | 8 | |
| 17 | 1999 | 8 | |
| 18 | 2004 | 8 | |
| 19 | Factor VII G331D: a variant molecule involving replacement of a residue in the substrate-binding region of the catalytic domain. | 1996 | 8 |
| 20 | 1987 | 7 |
About Muhammad Shurafa
Muhammad Shurafa is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Surgery, having authored 29 papers that have together received 912 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Platelet Disorders and Treatments (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (420 citations), Genetics (262 citations), Oncology (319 citations), Pathology and Forensic Medicine (142 citations) and Gastroenterology (36 citations). Muhammad Shurafa has collaborated with scholars based in United States. Frequent co-authors include Kenneth J. Kopecky, Frederick R. Appelbaum, Cheryl L. Willman, David R. Head, James H. Doroshow, Chatchada Karanes, Diane L. Persons, Harry E. Hynes, Marilyn L. Slovak and Robert T. Dorr. Their work appears in journals such as Blood, American Journal of Hematology, Genes Chromosomes and Cancer, Archives of Pathology & Laboratory Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.